NCT06798493

Brief Summary

Complex Regional Pain Syndrome (CRPS) is an orphan condition with no interventions proven effective in large-scale clinical trials. In-person clinical evaluations are required to make a CRPS diagnosis and determine study eligibility, making recruitment for CRPS trials challenging. To address this barrier, we will validate a self-report measure of CRPS symptom severity suitable for remote administration that was created by colleagues at Vanderbilt University. The aim of this study is to evaluate the correspondence at the item and total score level between the proposed self-report measure (CRPS Severity Score-Self Report; CSS-SR) and an existing validated measure of CRPS signs and symptoms derived from clinical history and physical examination data (CSS-Clinician version) and evaluate its diagnostic accuracy relative to clinically determined, criterion-based CRPS diagnosis using the Budapest criteria.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2025Dec 2026

First Submitted

Initial submission to the registry

January 22, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

January 27, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 29, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2026

Last Updated

February 13, 2026

Status Verified

January 1, 2026

Enrollment Period

1.9 years

First QC Date

January 22, 2025

Last Update Submit

February 11, 2026

Conditions

Keywords

CRPSComplex Regional Pain Syndromeself-reportComplex Regional Pain Syndrome Severity Score (CSS)

Outcome Measures

Primary Outcomes (1)

  • Concordance between CSS-Clinician and CSS-SR total scores

    Concordance between CSS-Clinician total scores, which will be on a numerical scale potentially ranging from 0-16, and CSS-SR total scores, which will be on a numerical scale potentially ranging from 0-13. Higher scores indicate greater CRPS symptom severity while lower scores indicate a lesser degree of symptom severity. Concordance (corrected for chance agreement) between CSS-Clinician and CSS-SR items and total scores will be assessed using intraclass correlations (ICCs; two-way random effects model; potential range = -1.00 to 1.00). Strength of agreement will be evaluated for descriptive purposes based on published recommendations: \< 0.50 = poor agreement, 0.50 - 0.75 = moderate agreement, 0.76 - 0.90 = good agreement, and \>0.90 = excellent agreement. All analyses will use the maximum number of cases available with a two-sided p\<0.05 criterion for statistical significance.

    Date of enrollment

Secondary Outcomes (1)

  • Diagnostic accuracy relative to clinically-determined, criterion-based CRPS diagnosis using the Budapest criteria

    Date of enrollment

Study Arms (2)

CRPS group

Patients suspected or diagnosed with unilateral CRPS type I or II of the upper or lower extremity

Other: Complex Regional Pain Syndrome (CRPS) Severity Score - Self Report

Non-CRPS group

Patients suspected or diagnosed with non-CRPS-related pain of the upper or lower extremities

Other: Complex Regional Pain Syndrome (CRPS) Severity Score - Self Report

Interventions

Self-report tool in a questionnaire format to capture CPRS Severity Score.

CRPS groupNon-CRPS group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hospital for Special Surgery Outpatient Pain Management Patients

You may qualify if:

  • years of age or older
  • Suspected or diagnosed with unilateral CRPS type I or II of the upper or lower extremity
  • Suspected or diagnosed with non-CRPS-related pain of the upper or lower extremities

You may not qualify if:

  • Bilateral CRPS
  • Total knee arthroplasty as the inciting event of CRPS
  • Less than 18 years of age
  • Non-English speaking
  • Inability to comprehend study protocol and questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital for Special Surgery

New York, New York, 10021, United States

Location

Related Publications (3)

  • Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011 Jun;38(6):1113-22. doi: 10.3899/jrheum.100594. Epub 2011 Feb 1.

    PMID: 21285161BACKGROUND
  • Deyo RA, Dworkin SF, Amtmann D, Andersson G, Borenstein D, Carragee E, Carrino J, Chou R, Cook K, DeLitto A, Goertz C, Khalsa P, Loeser J, Mackey S, Panagis J, Rainville J, Tosteson T, Turk D, Von Korff M, Weiner DK. Report of the NIH Task Force on research standards for chronic low back pain. J Pain. 2014 Jun;15(6):569-85. doi: 10.1016/j.jpain.2014.03.005. Epub 2014 Apr 29.

    PMID: 24787228BACKGROUND
  • Bruehl S. An update on the pathophysiology of complex regional pain syndrome. Anesthesiology. 2010 Sep;113(3):713-25. doi: 10.1097/ALN.0b013e3181e3db38.

    PMID: 20693883BACKGROUND

MeSH Terms

Conditions

Complex Regional Pain SyndromesPain

Condition Hierarchy (Ancestors)

Autonomic Nervous System DiseasesNervous System DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Alexandra Sideris, PhD

    Hospital for Special Surgery, New York

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2025

First Posted

January 29, 2025

Study Start

January 27, 2025

Primary Completion (Estimated)

December 29, 2026

Study Completion (Estimated)

December 29, 2026

Last Updated

February 13, 2026

Record last verified: 2026-01

Locations